Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Ayanin diacetate-induced cell death is amplified by TRAIL in human leukemia cells

Journal Article · · Biochemical and Biophysical Research Communications
; ; ;  [1]; ; ;  [2];  [3];  [1]
  1. Departamento de Bioquimica, Unidad Asociada al Consejo Superior de Investigaciones Cientificas, Universidad de Las Palmas de Gran Canaria, Plaza Dr. Pasteur s/n, 35016 Las Palmas de Gran Canaria (Spain)
  2. Departamento de Quimica, Universidad de Las Palmas de Gran Canaria, Instituto Canario de Investigacion del Cancer, 35017 Las Palmas de Gran Canaria (Spain)
  3. Instituto de Productos Naturales y Agrobiologia, Consejo Superior de Investigaciones Cientificas, Avda. Astrofisico F. Sanchez 3, 38206 La Laguna, Tenerife (Spain)

Highlights: Black-Right-Pointing-Pointer Ayanin diacetate as apoptotic inducer in leukemia cells. Black-Right-Pointing-Pointer Cell death was prevented by caspase inhibitors and by the overexpression of Bcl-x{sub L}. Black-Right-Pointing-Pointer The intrinsic and the extrinsic pathways are involved in the mechanism of action. Black-Right-Pointing-Pointer Death receptors are up-regulated and TRAIL enhances apoptotic cell death. -- Abstract: Here we demonstrate that the semi-synthetic flavonoid ayanin diacetate induces cell death selectively in leukemia cells without affecting the proliferation of normal lymphocytes. Incubation of human leukemia cells with ayanin diacetate induced G{sub 2}-M phase cell cycle arrest and apoptosis which was prevented by the non-specific caspase inhibitor z-VAD-fmk and reduced by the overexpression of Bcl-x{sub L}. Ayanin diacetate-induced cell death was found to be associated with: (i) loss of inner mitochondrial membrane potential, (ii) the release of cytochrome c, (iii) the activation of multiple caspases, (iv) cleavage of poly(ADP-ribose) polymerase and (v) the up-regulation of death receptors for TRAIL, DR4 and DR5. Moreover, the combined treatment with ayanin diacetate and TRAIL amplified cell death, compared to single treatments. These results provide a basis for further exploring the potential applications of this combination for the treatment of cancer.

OSTI ID:
22210323
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 1 Vol. 428; ISSN BBRCA9; ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation
Journal Article · Sat Aug 01 00:00:00 EDT 2015 · Toxicology and Applied Pharmacology · OSTI ID:22465792

Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression
Journal Article · Mon Mar 10 00:00:00 EDT 2008 · Experimental Cell Research · OSTI ID:21045954

TRAIL death receptors and cancer therapeutics
Journal Article · Thu Nov 01 00:00:00 EDT 2007 · Toxicology and Applied Pharmacology · OSTI ID:21077838